September 15, 2020New research1 suggests that two novel types of amphetamines may effectively treat attention deficit hyperactivity disorder (ADHD or ADD) in adults: SHP465 mixed amphetamine salts (MAS) and AR19 fast-release amphetamine sulfate.
The findings were announced at the Psych Congress Virtual Experience from September 11 to 13.The investigational stimulant AR19 is a pellets-in-capsule, fast-release amphetamine sulfate with physical and chemical barriers designed to prevent abuse by snorting, smoking, and intravenous injection.
A randomized-control trial2 was conducted on adults with ADHD, ages 18-55 years, to assess the safety and efficacy of AR19. 320 patients were randomly assigned placebo, 107 were assigned a 20 mg dose of.
Read more on additudemag.com